Comparison of MDP and Sestamibi Diagnostic Value for Palpable Breast Lesions
| Index | MDP | Sestamibi | P |
|---|---|---|---|
| Sensitivity | 65.9% (45.5%–79.9%) | 82.9% (68%–92%) | 0.11, NS |
| Specificity | 50.0% (15.7%–84.3%) | 87.5% (47.3%–99.7%) | 0.24, NS |
| LR, positive lesion | 1.3 (0.8–3.3) | 6.6 (1.7–37.1) | |
| LR, negative lesion | 0.7 (0.3–1.7) | 0.2 (0.09–0.4) |
NS = not statistically significant; LR = likelihood ratio.
Values in parentheses are confidence intervals.